The protein known as muscular LMNA-interacting protein refers to a protein that interacts with the LMNA gene product, lamin A/C, within muscle cells. Lamin A/C is a type of intermediate filament protein that provides structural support to the nucleus by forming part of the nuclear lamina, a dense fibrillar network inside the nuclear envelope.Mutations in the LMNA gene can lead to a variety of diseases collectively termed laminopathies, which often include muscle-related conditions such as Emery-Dreifuss muscular dystrophy, limb-girdle muscular dystrophy, and dilated cardiomyopathy with conduction system disease. These conditions can affect skeletal and cardiac muscle, leading to muscle weakness, contractures, and heart problems.
The muscular LMNA-interacting protein likely plays a role in maintaining nuclear integrity, mechano-transduction, and gene regulation within muscle cells by directly interacting with lamin A/C. Through this interaction, it may be involved in the mechanical stabilization of the nucleus, especially during muscle contraction and relaxation cycles. The protein may also be implicated in the organization of the nuclear envelope and chromatin structure, which is crucial for proper gene expression.In the context of laminopathies, the interaction between lamin A/C and the muscular LMNA-interacting protein may become disrupted, which can contribute to the pathogenesis of muscle degeneration and weakness. Understanding the specific functions of this interacting protein and its relationship with lamin A/C is essential for developing targeted therapies for diseases associated with LMNA mutations.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane activates NRF2 signaling pathway, which can have downstream effects on nuclear envelope proteins including LMNA. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Metformin activates AMPK, a master regulator of cellular energy homeostasis, potentially influencing LMNA-related cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, impacting chromatin structure and possibly affecting LMNA function. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Pioglitazone, a PPAR-gamma agonist, can modulate nuclear receptor activities, potentially impacting LMNA. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632, a ROCK inhibitor, can affect cytoskeletal dynamics, potentially influencing LMNA interactions in muscle cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, influences cellular growth and may indirectly affect LMNA function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, with its broad biological activities, may impact nuclear envelope integrity and LMNA interactions. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium, a GSK-3 inhibitor, could indirectly affect LMNA through Wnt signaling pathway modulation. | ||||||